Business Context and Reporting Period
Aimei Health Technology Co., Ltd. (AFJK) is a Cayman Islands exempted company and a special purpose acquisition company (SPAC) formed to pursue a business combination with healthcare innovation targets. The reporting period covers the three months ended March 31, 2025. The Company has not yet commenced operations and generates no operating revenue; its activities are limited to formation costs and the pursuit of a business combination. The Company is classified as a shell company, a smaller reporting company, and an emerging growth company.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Net Income | $184,662 | $755,500 |
| Operating Costs | $(413,414) | $(153,632) |
| Interest Income (Trust Account) | $598,076 | $909,132 |
| Cash (Operating) | $7,345 | $413,747 |
| Cash in Trust Account | $43,594,825 | $73,784,549 |
| Total Assets | $43,602,847 | $73,814,933 |
| Total Liabilities | $2,375,746 | $1,506,994 |
| Working Capital Deficit | $(1,677,724) | N/A |
| Extension Loan (Related Party) | $755,400 | $227,700 |
Material Changes vs. Prior Period
- Share Redemptions: On February 5, 2025, approximately 2,904,267 shares were redeemed at ~$10.77 per share, totaling ~$31.27 million. This significantly reduced the Trust Account balance from $73.8 million to $43.6 million and decreased public shares subject to redemption from 6.9 million to ~4.0 million.
- Operating Costs: Formation and operating costs increased by 169% to $413,414 from $153,632 in the prior year quarter.
- Interest Income: Interest earned on the Trust Account decreased by 34% to $598,076, reflecting the lower principal balance following redemptions and potentially lower interest rates.
- Related Party Debt: The "Extension loan – related party" increased to $755,400 from $227,700 as the Company funded six monthly extensions to delay the business combination deadline.
- Liquidity: Operating cash decreased to $7,345, indicating a reliance on related party funding for ongoing operations.
Outlook, Risks, and Management Commentary
- Business Combination Status: The Company entered a definitive Merger Agreement with United Hydrogen Group Inc. in June 2024. The deadline to consummate the transaction has been extended six times and is now set for June 6, 2025.
- Extension Mechanics: To extend the deadline, the Sponsor and United Hydrogen deposited monthly fees into the Trust Account. The fee structure was amended in February 2025 from $0.033 per share to a flat $150,000 per month for all outstanding shares. These deposits are evidenced by unsecured promissory notes.
- Going Concern: Management has raised substantial doubt about the Company's ability to continue as a going concern if a business combination is not completed by the deadline, as the Company would be required to liquidate and dissolve.
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of March 31, 2025.
- Deferred Fees: A deferred underwriting fee of $690,000 remains payable upon the closing of a business combination.
Investor Verification Checklist
- Extension Funding: Verify the ability of the Sponsor and United Hydrogen to continue funding the $150,000 monthly extension fees through June 6, 2025.
- Merger Conditions: Review the specific conditions in the Merger Agreement with United Hydrogen that could lead to termination, particularly regarding shareholder approvals and regulatory clearances.
- Operating Cash Runway: Assess the sufficiency of the remaining $7,345 in operating cash to cover expenses until the merger closes or liquidation occurs.
- Related Party Notes: Confirm the terms of the $755,400 in extension loans and whether they will be converted to equity or repaid upon closing.
- Redemption Risk: Monitor for further shareholder redemptions which could further deplete the Trust Account and impact the net tangible assets threshold.